Ortho Evra

On November 10, 2005, the FDA issued a warning stating that the Ortho Evra birth control patch contains higher levels of estrogen known to cause an increased risk of blood clots than average birth control pills. As a result, Ortho Evras was changed to reflect that women using the patch are exposed to 60 percent more estrogen than those who use a typical pill.

Since the arrival of the Ortho Evra birth control patch to the market in 2002, the FDA has received twenty-one reports of life-threatening blood clots and other ailments associated with the contraceptive patch. The birth control patch been linked to the deaths of at lease seventeen young American women who suffered heart attacks, blood clots and possible strokes over the past two years. Ortho McNeil, a subsidiary of Johnson & Johnson and the manufacturer of Ortho Evra, has aggressively marketed the birth control patch as a convenient alternative to oral birth control pills. Approximately 4 million women have used the Ortho Evra Birth Control Patch since it entered the market.

Call the offices of Evan D. Buxner today at 1-888-725-0503 or, email us for a free initial consultation to discuss your case and your rights under the law.